杭州德适生物科技股份有限公司（股票代码：02526，以下简称“德适-B”）于2026年4月22日披露2026年3月股份变动月报表。报告期内，公司已发行股本及注册股本均无变化，截至当月底仍为88,879,200股，未出现新增发行、购回、注销或库藏股变动。
根据公告，德适-B本月无股份期权或激励计划变动，也无购回或注销股份行为。公司确认，截至2026年3月31日，已满足相关上市规则及法律法规的合规要求，股本结构保持稳定。
上述月报由公司执行董事宋宁签署。公司表示将持续遵守香港联交所《上市规则》以及其他相关法律法规的要求，及时披露最新信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.